Genome Testing To Speed Clinical Trials Of Drugs In The Global Dermatology Drugs

Posted by sainath on September 10th, 2018

The dermatology drugs market includes medications that are used for the treatment of skin conditions such as dermatitis (including eczema), rosacea, hyperhidrosis, androgenic alopecia, onychomycosis, hair loss, acne, immune disorders (including psoriasis), microbial infections (bacterial, fungal, and viral), vascular and pigmented lesion removal, common warts, seborrheic keratosis, and other skin diseases The market numbers within this briefing are restricted to pharmaceutical (drug) treatments and do not cover biologic treatments for these conditions which are included in a separate briefing.

Dermatology drugs used to treat acne include local anesthetics, cleansers, anti-inflammatory agents, anti-infectives, emollients, and astringents. These drugs are available for both topical (external) use and internal use. These drugs can be sold as over-the-counter (OTC) as well as prescription drugs. Major OTC dermatological drugs include Differin, Lamisil, Monistat, and Abreva. Some of the major dermatology prescription drugs include Clobetasol propionate, Flucinonidei, Baxdela, Siliq, and Rhofade.

Read more at:

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report-2018

The global dermatology drugs market has been growing in the past years with a CAGR of almost 5%. The year 2017 recorded growth in this market with a net market value more than 18% higher than that of 2013, as per TBRC’s in-house consultants.

TBRC’s latest report show the historic and future trends in the market for each year with sourced reasons to support the growth claims.

The report also shows the global dermatology drugs market to grow at a higher CAGR by 2021 as compared to 2017, along with geographies best suited for investments with highest return rate.

Sample report at:

https://www.thebusinessresearchcompany.com/sample.aspx?id=272&type=smp

Drug manufacturing companies are using genome testing to reduce the time and costs spent in clinical trials. A clinical trial is a complex process and it often takes months for a drug to be available in the market. This deprives patients of cost-effective treatment. Researchers in the Rockefeller University used genomic testing and data analytics to predict the response of psoriasis patients for a given treatment. Genomic testing algorithms collect gene-expression data from skin biopsies and detect activity in 50,000 different genes. This technique can predict the response of a patient with an accuracy of 95% and within 12 weeks, thus saving significant time for clinical trials and the launch of new drugs.

Companies included in the report are Adobe Systems, Autodesk, Dassault Systemes, Hexagon, and Synopsys.

About The Business Research Company:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info